Apraclonidine (Sandoz Inc.)


Welcome to the PulseAid listing for the Apraclonidine drug offered from Sandoz Inc.. This Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc.
NON-PROPRIETARY NAME: Apraclonidine
SUBSTANCE NAME: APRACLONIDINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2009-07-19
END MARKETING DATE: 0000-00-00


Apraclonidine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionApraclonidine from Sandoz Inc.
LABELER NAME: Sandoz Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5.75(mg/mL)
START MARKETING DATE: 2009-07-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 61314-665_de886297-ac5b-5c43-bf59-b863e5daebd8
PRODUCT NDC: 61314-665
APPLICATION NUMBER: NDA020258

Other APRACLONIDINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn Inc.Apraclonidine Ophthalmic
Alcon Laboratories, Inc.IOPIDINE
Sandoz Inc.Apraclonidine